Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532473) titled 'REal World MAIA UK OutcomEs' on April 7.
Study Type: Observational
Primary Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Condition:
Myeloma
Recruitment Status: Not recruiting
Date of First Enrollment: July 2026
Target Sample Size: 300
Countries of Recruitment:
United Kingdom
To know more, visit https://clinicaltrials.gov/study/NCT07532473
Disclaimer: Curated by HT Syndication....